Method for reducing heterogeneity of antibodies and a process of producing the antibodies thereof
The present disclosure relates to a method of reducing heterogeneity in antibodies during culturing, wherein the heterogeneity is due to proportion of charge variant of the antibody. The disclosure also comprises a process of growing cells in a cell culture system that results in antibodies with the reduced heterogeneity. In one embodiment antibody heterogeneity is reduced by the addition of divalent transitional metal ions such as zinc (Zn 2+ ) to the cell culture medium. In another embodiment antibody heterogeneity is reduced by decreasing the osmolality of the cell culture medium.
1. A method of reducing heterogeneity in antibodies obtained by cell culturing by reducing the proportion of lysine residue on C-terminal of the antibodies, said method comprises adding a divalent transitional metal ion at a concentration ranging from 0.05 mM to 5 mM to the antibody producing culture medium or altering osmolality of the culture medium or a combination thereof to obtain said antibodies with reduced heterogeneity wherein the osmolality of the culture medium is reduced to provide osmolality ranging from 240 mOsm/Kg to 260 mOsm/Kg, wherein the cells are Chinese Hamster Ovary (CHO) cells.
2. The method as claimed in claim 1 , wherein the heterogeneity is due to proportion of charge variant of the antibody.
3. The method as claimed in claim 1 , wherein the heterogeneity is reduced by carrying out the said method for proportion of antibodies ranging from about 75% to about 100%.
4. The method as claimed in claim 1 , wherein the antibody is a naturally occurring antibody or a recombinant antibody selected from a group comprising monoclonal antibody, modified antibody, derivative of antibody and fragment of antibody or any combination thereof.
5. The method as claimed in claim 2 , wherein the reduction in heterogeneity of basic variant proportion of the antibody is from 3% to 30% and increase of main peak/0 Lysine of antibody is from 5% to 25%.
6. The method as claimed in claim 1 , wherein the metal ion is Zn +2 .
7. The method as claimed in claim 1 , wherein the culturing is fed batch culturing; and comprises mammalian cell culturing.
8. The method as claimed in claim 1 , wherein the addition of the divalent transitional metal ions is carried out firstly during cell growth phase and secondly during polypeptide production phase of the cell culturing;
or wherein the addition of the metal ion is carried out at an initial phase before said culturing of the cells.
9. A process for producing antibody having reduced heterogeneity by reducing the proportion of lysine residue on C-terminal of the antibody, said process comprising acts of:
a) culturing cells in culture medium for producing the antibody, and adding divalent transitional metal ions at a concentration ranging from 0.05 mM to 1.5 mM to the culture medium or altering osmolality of the culture medium or a combination thereof, wherein the osmoiality of the culture medium is reduced to provide osmolality ranging from 240 mOsm/Kg to 260 mOsm/Kg; and
b) recovering the antibody from the culture medium having the reduced heterogeneity.
10. The process as claimed in claim 9 (a), wherein the cells are cultured at a concentration ranging from about 0.5×10<sup>6</sup>cells/ml to about 0.6×10<sup>6</sup>cells/ml.
11. The process as claimed in claim 9 (a), wherein the culturing is carried out at temperatures ranging from about 36°C. to about 38° C.
12. The process as claimed in claim 10 , wherein the antibody is a naturally occurring antibody or a recombinant antibody selected from a group comprising monoclonal antibody, modified antibody, derivative of antibody and fragment of antibody or any combination thereof.
13. The process as claimed in claim 9 , In the heterogeneity is due to proportion of charge variant of the antibody.
14. The process as claimed in claim 9 , wherein the heterogeneity is reduced by carrying out the said method for proportion of antibodies ranging from about 75% to about 100%.
15. The method as claimed in claim 13 , wherein the reduction in heterogeneity of basic variant proportion of the antibody is from 3% to 30% and increase of main peak/0 Lysine of antibody is from 5% to 25%.
16. The process as claimed in claim 9 , wherein the culturing is fed batch culturing; and comprises mammalian cell culturing.
17. The process as claimed in claim 9 , wherein the metal ion is Zn +2 .
18. The process as claimed in claim 9 , wherein the addition of the divalent transitional metal ions is carried out firstly during cell growth phase and secondly during polypeptide production phase of the culturing at temperatures ranging from about of about 30 ° C. to about 32° C.; or wherein the addition of the metal divalent transitional ions is carried out at an initial phase before said culturing of the cells.
19. The process as claimed in claim 18 , wherein the cell growth phase has a concentration of cells ranging from about 12×10 6 cells/ml to about 13×10 6 cells/ml; and wherein the polypeptide production phase has a concentration of cells ranging from about 13×10 6 cells/ml cells/ml to about 15×10 6 cells/ml.